Screening mammography: Is it suitably targeted to older women who are most likely to benefit?
To determine whether screening mammography is suitably targeted to older women who are most likely to benefit. Prospective cohort study. New Haven County, Connecticut. Eight hundred forty-four community-dwelling older women were interviewed as part of the 1990 New Haven Established Populations for the Epidemiologic Study of the Elderly (EPESE) program. Mammography use was ascertained from Medicare Part B claims data. A four-level prognostic mortality index was developed using items previously shown to be predictive of mortality. Mammography use and all-cause mortality were evaluated by prognostic stage over a 5-year period, January 1, 1991, to December 31, 1995. Five-year mortality increased steadily with each prognostic stage (12% to 68%, P = .001), whereas the 5-year mammography use rate declined (48% to 7%, P = .001). Over half the women (53%) in the most favorable prognostic group did not receive a mammogram, whereas 13% in the two worst prognostic groups received at least one mammogram. Screening mammography may be underutilized among older women who are the most likely to benefit and overutilized among those who are unlikely to benefit.